Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-002193

Chief Financial Officer sold 10,000 shares at an average $139.94 ($1,399,390)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McAnear Justin J. · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +10,000 $5.04 $50,400 30,774 D
2021-01-04 Sale : show line 2 in the form −2,000 $139.08 $278,152 28,774 D
2021-01-04 Sale : show line 3 in the form −6,036 $139.91 $844,525 22,738 D
2021-01-04 Sale : show line 4 in the form −1,764 $140.78 $248,331 20,974 D
2021-01-04 Sale : show line 5 in the form −200 $141.91 $28,382 20,774 D
Open-market sales · 10,000 sh · avg $139.94 · $1,399,390

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-04 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −10,000 $5.04 2028-11-02 10,000 470,159 D
Loading xslF345X03/doc4.xml…